Transformative experience and social connectedness mediate the mood-enhancing effects of psychedelic use in naturalistic settings
Across six multiday mass gatherings in the US and UK with over 1,200 participants, psychedelic use was significantly associated with increased positive mood, an effect sequentially mediated by self‑reported transformative experiences and heightened social connectedness. These relationships remained after controlling for demographics and other psychoactive substances and were particularly pronounced for use within the preceding 24 hours.
Abstract
Past research suggests that use of psychedelic substances such as LSD or psilocybin may have positive effects on mood and feelings of social connectedness. These psychological effects are thought to be highly sensitive to context, but robust and direct evidence for them in a naturalistic setting is scarce. In a series of field studies involving over 1,200 participants across six multiday mass gatherings in the United States and the United Kingdom, we investigated the effects of psychedelic substance use on transformative experience, social connectedness, and positive mood. This approach allowed us to test preregistered hypotheses with high ecological validity and statistical precision. Controlling for a host of demographic variables and the use of other psychoactive substances, we found that psychedelic substance use was significantly associated with positive mood—an effect sequentially mediated by self-reported transformative experience and increased social connectedness. These effects were particularly pronounced for those who had taken psychedelic substances within the last 24 h (compared to the last week). Overall, this research provides robust evidence for positive affective and social consequences of psychedelic substance use in naturalistic settings.
Research Summary of 'Transformative experience and social connectedness mediate the mood-enhancing effects of psychedelic use in naturalistic settings'
Introduction
Forstmann and colleagues situate their study within a renewed scientific interest in the therapeutic and psychological effects of serotonergic psychedelics (for example, psilocybin and LSD). They note that controlled laboratory work and large-scale surveys have reported positive effects on mood, well-being and social attitudes, but that both approaches have limitations: laboratory studies often have small samples and artificial settings that do not reflect typical use, while retrospective surveys risk recall bias and demand effects. The authors emphasise the importance of "set and setting"—the influence of intrapersonal and environmental context on psychedelic effects—and argue that evidence from naturalistic settings is scarce and needed to understand how these substances affect mood and social connectedness in everyday use. To address this gap, the study asked whether recent psychedelic use at multiday mass gatherings predicts positive mood and whether two psychological processes—self-reported transformative experience (TE) and increased social connectedness—explain that relationship. The researchers preregistered hypotheses and designed a field study to compare very recent (past 24 h) versus moderately recent (past week) psychedelic use, while controlling for use of other psychoactive substances and demographic covariates, thereby aiming to capture acute and postacute effects with greater ecological validity than prior work.
Expert Research Summaries
Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.
Study Details
- Study Typeindividual
- Journal
- Compounds
- Topics
- Author
- APA Citation
Forstmann, M., Yudkin, D. A., Prosser, A. M. B., Heller, S. M., & Crockett, M. J. (2020). Transformative experience and social connectedness mediate the mood-enhancing effects of psychedelic use in naturalistic settings. Proceedings of the National Academy of Sciences, 117(5), 2338-2346. https://doi.org/10.1073/pnas.1918477117
References (17)
Papers cited by this study that are also in Blossom
King, C., Nichols, D. E. · Nature Reviews Neuroscience (2013)
Johansen, P. Ø., Krebs, T. S. · Journal of Psychopharmacology (2015)
Bogenschutz, M. P., Johnson, M. W. · Progress in Neuro-Psychopharmacology and Biological Psychiatry (2016)
Gasser, P., Holstein, D., Michel, Y. et al. · Journal of Nervous and Mental Disease (2014)
Palhano-Fontes, F., Barreto, D., Onias, H. et al. · Psychological Medicine (2018)
Preller, K. H., Pokorny, D., Hock, A. et al. · PNAS (2016)
Pokorny, T., Preller, K. H., Kometer, M. et al. · International Journal of Neuropsychopharmacology (2017)
Forstmann, M., Sagioglou, C. · Journal of Psychopharmacology (2017)
Hartogsohn, I. · Drug Science Policy and Law (2017)
Griffiths, R. R., Johnson, M. W., Richards, W. A. et al. · Journal of Psychopharmacology (2017)
Show all 17 referencesShow fewer
Nour, M. R., Evans, J., Nutt, D. J. et al. · Frontiers in Human Neuroscience (2016)
Griffiths, R. R. · Journal of Psychopharmacology (2008)
Maclean, K. A., Johnson, M. W., Griffiths, R. R. · Journal of Psychopharmacology (2011)
Roseman, L., Nutt, D. J., Carhart-Harris, R. L. · Frontiers in Pharmacology (2018)
Watts, R., Day, C. M., Krzanowski, J. et al. · Journal of Humanistic Psychology (2017)
Carhart-Harris, R. L., Erritzoe, D., Haijen, E. C. H. M. et al. · Psychopharmacology (2017)
Hendricks, P. S., Crawford, M. S., Cropsey, K. L. et al. · Journal of Psychopharmacology (2017)
Cited By (39)
Papers in Blossom that reference this study
Cherniak, A. D., Granqvist, P., Mikulincer, M. et al. · Journal of Psychoactive Drugs (2026)
Zhou, K., De Wied, D., Carhart-Harris, R. L. et al. · PNAS (2025)
Ertl, N., Ashraf, I., Azizi, L. et al. · Biorxiv (2025)
Stroud, J., Rice, C., Orsini, A. et al. · Psychopharmacology (2024)
Yaden, D. B., Goldy, S. P., Weiss, B. et al. · Nature Reviews Psychology (2024)
Simonsson, O., Osika, W., Stenfors, C. U. D. et al. · Psychological Medicine (2023)
Peck, S. K., Shao, S., Grue, T. et al. · Nature Medicine (2023)
Heifets, B. D., Olson, D. E. · Neuropsychopharmacology (2023)
Adamska, I., Finc, K. · Psychopharmacology (2023)
Lake, S., Lucas, P. · Psychedelic Medicine (2023)
Show all 39 papersShow fewer
Weiss, B., Sleep, C., Miller, J. D. et al. · Journal of Personality Disorders (2023)
Brasher, T., Rosen, D., Spinella, M. · International Journal of Wellbeing (2023)
Forstmann, M., Kettner, H. S., Sagioglou, C. et al. · Journal of Psychopharmacology (2023)
Peterson, A., Largent, E. A., Sisti, D. et al. · AJOB Neuroscience (2022)
Dourron, H. M., Strauss, C., Hendricks, P. S. · Pharmacological Reviews (2022)
Monroy, M., Keltner, D. · Perspectives on Psychological Science (2022)
Watts, R., Kettner, H., Gandy, S. et al. · Psychopharmacology (2022)
Costa, M. A. · Journal of Psychoactive Drugs (2022)
van Elk, M., Yaden, D. B. · Neuroscience and Biobehavioral Reviews (2022)
Glowacki, D. R., Wonnacott, M. D., Freire, R. et al. · Scientific Reports (2022)
Forstmann, M., Sagioglou, C. · European Psychologist (2022)
Pots, W., Chakhssi, F. · Frontiers in Psychology (2022)
Raison, C. L., Jain, R., Jain, S. et al. · Frontiers in Psychiatry (2022)
Qiu, X., Minda, J. P. · Psyarxiv (2021)
Nygart, V., Pommerencke, L. M., Carhart-Harris, R. L. et al. · Frontiers in Psychology (2021)
Earp, B. D., Repantis, D., Langlitz, N. et al. · Frontiers in Psychiatry (2021)
Timmermann, C., Kettner, H., Letheby, C. et al. · Scientific Reports (2021)
Roseman, L., Ron, Y., Saca, A. et al. · Frontiers in Pharmacology (2021)
Hartogsohn, I. · Frontiers in Pharmacology (2021)
Van Elk, M., Fejer, G., Lempe, P. et al. · Psychopharmacology (2021)
Carhart-Harris, R. L., Wagner, A. C., Agrawal, M. et al. · Journal of Psychopharmacology (2021)
Kettner, H., Rosas, F. E., Timmermann, C. et al. · Frontiers in Pharmacology (2021)
Qiu, T. T., Minda, J. P. · Psyarxiv (2021)
Forstmann, M., Sagioglou, C. · Public Understanding of Science (2020)
Stauffer, C., Anderson, B. T., Ortigo, K. M. et al. · ACS Pharmacology and Translational Science (2020)
Nayak, S., Johnson, M. W. · Pharmacopsychiatry (2020)
Gandy, S., Forstmann, M., Carhart-Harris, R. L. et al. · Health Psychology Open (2020)
Anderson, B. T., Danforth, A. L., Daroff, R. et al. · EClinicalMedicine (2020)
Zeifman, R. J., Wagner, A. C., Watts, R. et al. · Frontiers in Psychiatry (2020)
Your Personal Research Library
Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.